The British Committee for Standards in Haematology
Welcome to the British Committee for Standards in Haematology.
BCSH provides up to date evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease. The guidelines are written according to the BCSH process by a team of expert Consultants and clinical scientists currently practicing in the UK.
This organisation cannot give advice on individual patient management.
BCSH is a sub-committee of the British Society for Haematology. To find out more about the activities of the society and the benefits of joining please visit the main website.
If you wish to be informed of the publication of new BCSH guidelines subscribe to our guideline alerts by completing the form via this link.
RECENTLY PUBLISHED HAEMATOLOGY GUIDELINES
Issued: Feb 28, 2014
Issued: Feb 21, 2014
This guideline is updated from 2010 version. In 2013 changes were made in section 2.4 (pages 7-8), and levels of evidence converted to GRADE system. A further addendum was made in 2014 to section 7.1.2 (page 22) and section 9.4 (pages 35-36). References for these sections have been updated to 2014.
Issued: Jan 23, 2014
Issued: Dec 4, 2013
Note: The MDS guideline committee would like to correct an error on page 506 regarding cytogenetic analysis in this guidelines article. It should read 'cytogenetic analysis should be performed on at least 20 metaphases and should be reported in accordance with the International System Recommendations'.
There are many ways for members of the British Society for Haematology to become involved in BCSH from joining the sounding board that reviews and comments on the guidelines prior to publication to becoming part of the guideline Writing Groups or Task Forces.
To find out more or to express an interest in becoming involved please visit the ‘become involved’ section of the website.